cholecystitis and glp 1 GLP-1s & Gallbladder: What to Know Gallbladder Risks with GLP-1 Medications

Recently, two randomized controlled trials (RCTs) demonstrated that tirzepatide, a dual GLP-1/GIP receptor agonists, reduced the AHI and hypoxic burden, and improved sleep-related patient-reported outcomes among individuals with moderate-to-severe OSA [24]

44 were supplemented with L-carnitine (15 mg/kg iv after each hemodialysis for 6 months), while 39 took placebo

If it looks cloudy or has visible particles after 2 minutes of gentle swirling, something went wrong

Choline is an essential micronutrient for cholinergic transmission and, by extension, cognitive function

This dual action gives tirzepatide an edge in effectiveness for many people